LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

LLY

749.48

-0.89%↓

JNJ

176.96

-0.68%↓

ABBV

217.85

-0.57%↓

UNH

348.05

-0.48%↓

AZN

77.88

-0.5%↓

Home・Listă Acțiuni・Minerva Neurosciences Inc

Minerva Neurosciences Inc

Închisă

2.07 -0.48

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

2.02

Maxim

2.16

Indicatori cheie
By Trading Economics
P/E Medie Sector	1.381 35.664
EPS	-0.43
Angajați	8

Dividende
By Dow Jones
Următoarele câștiguri	3 nov. 2025

Statistici piață
By TradingEconomics
Capitalizare de piață	2.3M 12M
Deschiderea anterioară	2.55
Închiderea anterioară	2.07

Minerva Neurosciences Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

15 sept. 2025, 22:39 UTC

Achiziții, Fuziuni, Preluări

CSL Agrees to Deal to Advance Coagulation Treatment, May Acquire Developer

15 sept. 2025, 16:43 UTC

Principalele dinamici ale pieței

Strive Shares Sink on Board Disclosure; Bitcoin Treasury Strategy

15 sept. 2025, 16:42 UTC

Principalele dinamici ale pieței

Helius Medical Tech Jumps on Funding to Launch Solana Treasury

15 sept. 2025, 16:35 UTC

Principalele dinamici ale pieței

Chegg to Pay $7.5 Million to Settle FTC Claims Over Subscription Cancellation Process

15 sept. 2025, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 sept. 2025, 23:46 UTC

Market Talk

Nikkei May Rise as Fed Rate Cut Hopes Support Stocks -- Market Talk

15 sept. 2025, 23:34 UTC

Market Talk

Gold Steady Ahead of FOMC Meeting, Major U.S. Economic Data -- Market Talk

15 sept. 2025, 22:48 UTC

Market Talk

FOMC May Opt to Play Catch Up With Rate Cuts -- Market Talk

15 sept. 2025, 22:12 UTC

Achiziții, Fuziuni, Preluări

CSL Expects Commercial Launch in 2029

15 sept. 2025, 22:12 UTC

Achiziții, Fuziuni, Preluări

CSL Says VarmX to Receive Further Commercial Milestones Afterwards

15 sept. 2025, 22:11 UTC

Achiziții, Fuziuni, Preluări

CSL Says VarmX to Receive Payments of Up to $388 Million Up to Launch of VMX-C001

15 sept. 2025, 22:11 UTC

Achiziții, Fuziuni, Preluări

CSL to Have Right to Exercise Option Based on Phase 3 Data

15 sept. 2025, 22:10 UTC

Achiziții, Fuziuni, Preluări

CSL to Make Upfront Payment to VarmX of $117 Million for Exclusive Option to Acquire Company

15 sept. 2025, 21:16 UTC

Achiziții, Fuziuni, Preluări

Chord Energy: Assets Have a Low Avg NYMEX WTI Breakeven and Are Immediately Competitive for Capital

15 sept. 2025, 21:16 UTC

Achiziții, Fuziuni, Preluări

Chord Energy: Assets Have Significant Overlap With Existing Footprint, Setting the Stage for Long-Lateral Development

15 sept. 2025, 21:15 UTC

Achiziții, Fuziuni, Preluări

Chord Energy to Buy 48,000 Net Acres in the Williston Core

15 sept. 2025, 21:14 UTC

Achiziții, Fuziuni, Preluări

Chord Energy to Buy Assets in Williston Basin From Exxon's XTO Energy and Affiliates for $550M

15 sept. 2025, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

15 sept. 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

15 sept. 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

15 sept. 2025, 19:29 UTC

Market Talk

U.S. Natural Gas Gains on Warmer Weather Outlook -- Market Talk

15 sept. 2025, 19:14 UTC

Market Talk

Attacks on Russia Lifts Oil Price Despite Shaky Fundamentals -- Market Talk

15 sept. 2025, 18:16 UTC

Market Talk

Gold Powers to New High -- Market Talk

15 sept. 2025, 18:05 UTC

Market Talk

Easing Autonomous Vehicle Regulations Will Begin Tesla's Next Chapter -- Market Talk

15 sept. 2025, 17:50 UTC

Achiziții, Fuziuni, Preluări

U.S. Reaches Outline of Deal With China Over TikTok -- 2nd Update

15 sept. 2025, 17:10 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

15 sept. 2025, 17:10 UTC

Market Talk

S&P Expects Fed, BOC to Cut Rates -- Market Talk

15 sept. 2025, 16:52 UTC

Market Talk

Copper Climbs as Traders Brace for U.S. Rate Cut -- Market Talk

15 sept. 2025, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

15 sept. 2025, 16:20 UTC

Market Talk

Câștiguri

Auto & Transport Roundup: Market Talk

Comparație

Modificare preț

Minerva Neurosciences Inc Așteptări

Consens privind evaluarea

By TipRanks

0 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 0 analiști care au acordat evaluări ale acțiunilor Minerva Neurosciences Inc - Dist în ultimele 3 luni.

Date financiare

Despre Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.